 | 3 Groundbreaking Genomics Stocks to Buy Now (NVTA)
marketbeat.com - January 8 at 6:58 PM |
| Invitae (NYSE:NVTA) Stock Rating Lowered by BidaskClub
marketbeat.com - December 16 at 7:33 AM |
| Invitae (NYSE:NVTA) Rating Increased to Hold at Zacks Investment Research
marketbeat.com - November 18 at 5:20 AM |
| Zacks Investment Research Downgrades InVitae (NYSE:NVTA) to Hold
marketbeat.com - October 16 at 5:26 AM |
| InVitae (NYSE:NVTA) Coverage Initiated at Morgan Stanley
marketbeat.com - September 9 at 7:11 AM |
| InVitae (NYSE:NVTA) Price Target Raised to $37.25
marketbeat.com - August 5 at 8:37 AM |
 | Invitae teams up with healthcare giants to develop MRD detection panel - Seeking Alpha
seekingalpha.com - January 14 at 8:55 PM |
 | Leading Biopharmaceutical Companies Select Invitae to Develop Standardized Panel to Detect Molecular Residual Disease (MRD) in Patients with Acute Myeloid Leukemia (AML) - PRNewswire
prnewswire.com - January 14 at 8:55 PM |
 | Leading Biopharmaceutical Companies Select Invitae to Develop Standardized Panel to Detect Molecular Residual Disease (MRD) in Patients with Acute Myeloid Leukemia (AML)
finance.yahoo.com - January 14 at 8:55 PM |
 | Pacific Biosciences and Invitae to Develop Ultra-High-Throughput Clinical Whole Genome Sequencing Platform - GlobeNewswire
globenewswire.com - January 13 at 10:31 PM |
|
 | Invitae (NYSE:NVTA) Stock Price Up 7.9%
americanbankingnews.com - January 13 at 9:41 PM |
 | Why Invitae Stock Flew Higher Today - Motley Fool
fool.com - January 13 at 5:31 PM |
 | Why Is It Moving? Looking At Invitae's Price Action Today - Benzinga
benzinga.com - January 13 at 12:30 PM |
| Concert Genetics Launches Preferred Laboratory Network - PRNewswire
prnewswire.com - January 13 at 7:29 AM |
| News Flash: 8 Analysts Think Invitae Corporation (NYSE:NVTA) Earnings Are Under Threat - Yahoo Finance
finance.yahoo.com - January 13 at 7:29 AM |
| News Flash: 8 Analysts Think Invitae Corporation (NYSE:NVTA) Earnings Are Under Threat
finance.yahoo.com - January 13 at 7:29 AM |
| These 3 Big 2020 Stock Market Winners Took Big Hits Monday - Motley Fool
fool.com - January 12 at 8:32 AM |
 | Notable Monday Option Activity: NVTA, ATSG, KTB
nasdaq.com - January 12 at 3:31 AM |
| Invitae (NYSE:NVTA) Stock Price Down 10.2%
americanbankingnews.com - January 11 at 9:16 PM |
| Looking Into Invitae's Return On Capital Employed - Yahoo Finance
finance.yahoo.com - January 11 at 5:20 PM |
| Invitae Reports Preliminary 2020 Financial Results of More Than $278 Million in Revenue and More Than 655,000 in Billable Volume - Yahoo Finance
finance.yahoo.com - January 11 at 5:20 PM |
| Looking Into Invitae's Return On Capital Employed
benzinga.com - January 11 at 12:18 PM |
 | A new JPM: Biotech's big meeting week goes virtual with swag and questions - San Francisco Business Times
bizjournals.com - January 8 at 3:05 PM |
| NVTA Crosses Above Average Analyst Target - Nasdaq
nasdaq.com - January 8 at 3:05 PM |
| Invitae (NYSE:NVTA) Trading 5.9% Higher
americanbankingnews.com - January 5 at 9:18 PM |
| We Found a Bubble—but It May Not Be What You Think It Is
finance.yahoo.com - January 1 at 1:14 PM |
| We Found a Bubble–but It May Not Be What You Think It Is
finance.yahoo.com - December 31 at 7:21 PM |
| Invitae (NYSE:NVTA) Trading Down 5.4%
americanbankingnews.com - December 31 at 7:14 PM |
| Colorado biotech firms raised a combined $2.6 billion in 2020 - Denver Business Journal
bizjournals.com - December 31 at 12:01 AM |
| Invitae to Present at the 39th Annual J.P. Morgan Healthcare Conference - Yahoo Finance
finance.yahoo.com - December 29 at 7:58 AM |
|
| Jason W. Myers Sells 48,971 Shares of Invitae Co. (NYSE:NVTA) Stock
americanbankingnews.com - December 29 at 5:44 AM |
| Are Genomic Stocks Are The Next FANG Stocks? - Yahoo Finance
finance.yahoo.com - December 24 at 1:48 PM |
 | Best Biotech Stocks to Buy for 2021 - TheStreet
thestreet.com - December 24 at 1:48 PM |
| Are Genomic Stocks Are The Next FANG Stocks? - Benzinga
benzinga.com - December 24 at 8:48 AM |
 | The Top Five Hypergrowth Industries I'm Targeting In 2021 - Forbes
forbes.com - December 23 at 12:12 PM |
| Global Prenatal Testing and Newborn Screening Market Report 2020-2030: COVID-19 Growth and Change - Market to Recover in 2023 to Reach $6.04 Bn after a -4.79% Decline in 2020 - Yahoo Finance
finance.yahoo.com - December 22 at 5:29 AM |
 | Editas surges 50% as ARK founder Cathie Wood sees genomic stocks driving returns for the next 5 years - Business Insider
businessinsider.com - December 21 at 5:41 PM |
| Invitae: Network Strategy And Industry Tailwinds Should Offer Path To Profitability - Seeking Alpha
seekingalpha.com - December 21 at 7:39 AM |
| Is BJ Stock Buy Or Sell? - Yahoo Finance
finance.yahoo.com - December 20 at 7:56 PM |
| Invitae Corp (NVTA) COO Kenneth D. Knight Sold $680,901 of Shares - Yahoo Finance
finance.yahoo.com - December 19 at 1:37 AM |
| Invitae Introduces Routine Exome Reanalysis to Help Patients Receive Diagnoses Faster - PRNewswire
prnewswire.com - December 17 at 6:19 PM |
| Invitae Introduces Routine Exome Reanalysis to Help Patients Receive Diagnoses Faster - Yahoo Finance
finance.yahoo.com - December 17 at 1:18 PM |
| Invitae Introduces Routine Exome Reanalysis to Help Patients Receive Diagnoses Faster
finance.yahoo.com - December 17 at 8:17 AM |
 | Colorado's Life Sciences Ecosystem Raises $1.2 Billion in 2020 - Business Wire
businesswire.com - December 15 at 2:07 PM |
| Genomics testing provider ArcherDX officially withdraws $100 million IPO following acquisition by Invitae - Nasdaq
nasdaq.com - December 14 at 11:04 PM |
| Notable Friday Option Activity: VIAC, NVTA, NVAX
nasdaq.com - December 12 at 10:24 AM |
| Invitae to Present New Data Supporting Genetic Testing for All Breast Cancer Patients at the 2020 San Antonio Breast Cancer Symposium - PRNewswire
prnewswire.com - December 9 at 8:28 AM |
| Invitae to Present New Data Supporting Genetic Testing for All Breast Cancer Patients at the 2020 San Antonio Breast Cancer Symposium
finance.yahoo.com - December 9 at 8:28 AM |
| Stock Alert: Invitae Corporation Touches New High - Nasdaq
nasdaq.com - December 7 at 5:03 PM |
| New Study Highlights the Importance of Genetic Testing for Pancreatic Cancer Patients - PRNewswire
prnewswire.com - November 19 at 6:05 PM |
| New Study Highlights the Importance of Genetic Testing for Pancreatic Cancer Patients
finance.yahoo.com - November 19 at 1:05 PM |
| Imagine Holding Invitae (NYSE:NVTA) Shares While The Price Zoomed 557% Higher - Yahoo Finance
finance.yahoo.com - November 11 at 12:40 AM |
| Imagine Holding Invitae (NYSE:NVTA) Shares While The Price Zoomed 557% Higher
finance.yahoo.com - November 10 at 12:38 PM |
| Invitae: Growth With Massive Dilution
seekingalpha.com - November 9 at 8:21 PM |
| Passage Bio and Invitae Announce Collaboration to Facilitate Genetic Testing to Support Early Diagnosis and Greater Awareness of Clinical Trials for Patients with GM1 - GlobeNewswire
globenewswire.com - November 9 at 10:20 AM |
| Invitae Reports $68.7 Million in Revenue Driven by 170,000 Samples Accessioned in the Third Quarter of 2020 - Yahoo Finance
finance.yahoo.com - November 7 at 7:53 PM |
